Inicio › Cáncer de pulmón de células no pequeñas › Delaware

Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Delaware

21 estudios sobre Cáncer de pulmón de células no pequeñas buscan participantes en Delaware.

Ciudades en Delaware

Texto oficial del estudio (inglés)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT04267848

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Medical Oncology Hematology Consultants, PA, Newark

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07361497

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07388524

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06498635

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Medical Oncology Hematology Consultants, PA, Newark

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07144280

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Research Site, Newark

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06868277

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

ChristianaCare Health System, Newark

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07154290

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Medical Oncology Hematology Consultants Helen F Graham Cancer Center, Newark

ReclutandoFase 3

Edades de 18 a 100 · Todos los sexos · Actualizado el 25 sept 2026 · NCT05920356

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

ChristianaCare Helen F Graham Cancer Center and Research Institute, Newark

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06667076

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Medical Oncology Hematology Consultants, PA, Newark

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06875310

An External Control Arm Study in Non-Small Cell Lung Cancer

Bayhealth Medical Center, Kent Campus, Dover
Bayhealth Medical Center- Sussex Campus, Milford

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07174388

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Bayhealth Cancer Center- Kent, Dover
Bayhealth Cancer Center- Sussex, Milford

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07028489

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Research Site, Newark

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT06692738

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Medical Oncology Hematology Consultants, Newark

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT04585750

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Research Site, Newark

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07291037

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Bayhealth Hospital Kent Campus, Dover
Bayhealth Hospital Sussex Campus, Milford

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Bayhealth Hospital Kent Campus, Dover
Bayhealth Hospital Sussex Campus, Milford

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 may 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
y 1 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 may 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Bayhealth Hospital Kent Campus, Dover
Bayhealth Hospital Sussex Campus, Milford

ReclutandoFase 2

18 Minutes · Todos los sexos · Actualizado el 5 may 2026 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
y 1 más

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 mar 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Newark

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.